Deepinder Goyal Announces a $25 Million Fund backed by Personal Investment Supporting Research in Aging Biology, Evolution, and Longevity

Continue Research, a 2-year-old research effort to identify and study upstream mechanisms in biology, started by Deepinder Goyal, has announced a $25 million fund to back researchers, funded by personal investment, and is not a part of Eternal.

The next breakthroughs in aging biology are hiding in plain sight, emerging not from added complexity but from uncovering foundational mechanisms that control everything downstream.

A $25M fund supports researchers testing ideas so simple they’re often overlooked, hypotheses that provoke the thought: “It can’t be that straightforward.”

What if aging isn’t complex but an engineering problem? What if exercise works through one key mechanism, not many? Focus is on root causes and physical realities that could upend hundreds of minor theories.

Funding Structure

Moonshots ($50K–$250K): Test deceptively simple ideas in 6–12 months. Most fail; the rare success changes everything.

Deep Dives ($250K–$2M): Explore promising mechanisms in 1–3 years to prove or disprove key hypotheses.

For the past two years, Continue has focused on identifying upstream biological mechanisms, simple levers that ripple across the body. The approach treats biology as a system rather than a collection of isolated parts.

Now, Continue Research expands into a $25M fund, supporting researchers bold enough to ask simpler, high-impact questions.

Continue is not a company or startup; it’s a research team plus seed fund for the next phase of human health. All findings are open source, intended for the field, and aimed at interventions accessible to everyone, not just the elite.